Alzheimer’s disease: Channeling APP to non-amyloidogenic processing
- 1 June 2005
- journal article
- review article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 331 (2) , 375-378
- https://doi.org/10.1016/j.bbrc.2005.03.074
Abstract
No abstract availableKeywords
This publication has 34 references indexed in Scilit:
- Modulation of Statin-Activated Shedding of Alzheimer APP Ectodomain by ROCKPLoS Medicine, 2005
- Amyloid-beta precursor protein processing in neurodegenerationCurrent Opinion in Neurobiology, 2004
- Amyloid precursor protein metabolism is regulated toward alpha-secretase pathway by Ginkgo biloba extractsNeurobiology of Disease, 2004
- Atorvastatin‐induced activation of Alzheimer's α secretase is resistant to standard inhibitors of protein phosphorylation‐regulated ectodomain sheddingJournal of Neurochemistry, 2004
- Nonsteroidal Anti-Inflammatory Drugs for the Prevention of Alzheimer’s Disease: A Systematic ReviewNeuroepidemiology, 2004
- ADAMs family members as amyloid precursor protein α‐secretasesJournal of Neuroscience Research, 2003
- Non-steroidal Anti-inflammatory Drugs and Cyclooxygenase in Alzheimer s DiseaseCurrent Drug Targets, 2003
- Neuroprotection and neurorescue against Aβ toxicity and PKC‐dependent release of non‐amyloidogenic soluble precursor protein by green tea polyphenol (‐)‐epigallocatechin‐3‐gallateThe FASEB Journal, 2003
- Memory-enhancing effects of secreted forms of the β-amyloid precursor protein in normal and amnestic miceProceedings of the National Academy of Sciences, 1998
- Secreted forms of β‐amyloid precursor protein modulate dendrite outgrowth and calcium responses to glutamate in cultured embryonic hippocampal neuronsJournal of Neurobiology, 1994